Cincinnati, OH, United States of America

Jules Freedman


 

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Thiensville, WI (US) (1976)
  • Cincinnati, OH (US) (1978 - 2000)

Company Filing History:


Years Active: 1976-2000

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovations of Jules Freedman: A Pioneer in Pharmaceutical Patents

Introduction

Jules Freedman, an accomplished inventor hailing from Cincinnati, OH, has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating mental health conditions and combating drug resistance in tumors. With a remarkable portfolio of 15 patents, Freedman's work demonstrates a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Two of Freedman’s most recent patents represent groundbreaking advancements in medicine. The first is a novel group of compounds, including certain aryloxy indanamines, which show potential as antidepressants and inhibitors of synaptic norepinephrine and serotonin uptake. This invention promises improvements in the treatment of depression by targeting neurotransmitter reuptake mechanisms. The second patent focuses on reversing multi-drug resistance in tumors through the use of triphenyl-azacycloalkane derivatives. These innovative compounds act by inhibiting the p-glycoprotein pump, which becomes active during the late stages of tumor development, thereby providing new avenues for treatment in challenging cases of drug-resistant cancer.

Career Highlights

Freedman's career features substantial engagement with prominent pharmaceutical companies, notably Merrell Dow Pharmaceuticals and Merrell Pharmaceuticals, Inc. His tenure at these companies allowed him to cultivate his research expertise and translate his innovative ideas into tangible products that benefit patients. Throughout his career, Freedman has focused on overcoming challenges in drug development and offering new hope for patients suffering from mental health issues and complex medical conditions.

Collaborations

Collaboration has been key to Freedman's success. He has worked alongside notable industry experts, including Mark W. Dudley and Alan J. Bitonti. These partnerships have facilitated the rapid development and enhancement of his innovative patent portfolio, allowing for a cross-pollination of ideas and techniques that ultimately enrich the field of pharmacology.

Conclusion

Jules Freedman stands as a testament to the powerful impact of innovation in the pharmaceutical realm. His contributions through 15 patents not only pave the way for new treatment options but also inspire future generations of inventors and researchers. As the pharmaceutical industry continues to evolve, Freedman’s work will undoubtedly remain a cornerstone in the fight against both mental health disorders and multi-drug resistant tumors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…